Channels - Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer :: FRELIP Discovery

Similar Items: Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer

Quick Look
Pan cancer analyses and clinical cohort validation identify HOMER3 as colorectal cancer prognostic biomarker and therapeutic target
Quick Look
Multi-omics analysis identifies GINS1 as a prognostic biomarker in lung adenocarcinoma, linked to macrophage polarization and tumor cell survival
Quick Look
Multi-omic discovery of SCG5 as a shared driver and prognostic biomarker in head-neck and non-small cell lung cancers
Quick Look
A machine learning-guided epithelial plasticity score refines prognostication and immune-context stratification in muscle-invasive bladder cancer
Quick Look
Integrating multi-omics and clinical management in breast cancer: a comprehensive review
Quick Look
Integrative analysis identifies ALDOA and PGK1 as prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma
Quick Look
Multi-omics and network toxicology prioritize ADAMTS13 as a candidate gene computationally linked to TDCPP targets in hepatocellular carcinoma
Quick Look
Multi-omics pan-cancer analysis reveals heterogeneous BCAA metabolism and its impact on the tumor immune microenvironment and prognosis
Quick Look
Artificial intelligence and multi-omics revealed the authentic regulation of ADP-ribosylation in modulation Treg/Th17 ecosystem and multi-target therapeutic strategy enrichment for HBV+ Hepatocellular Carcinoma patients
Quick Look
Multi-omics profiling reveals LncRNA ENSG00000253374 as a regulator of GLS-mediated cuproptosis and platinum resistance in ovarian cancer
Quick Look
The potential utility of in-silico approach in identifying phytochemicals against various targets for the management of lung cancer
Quick Look
Multi-omics and metabolic flux modeling reveal that macrophage CYP27A1-derived 26-hydroxycholesterol drives immunosuppression and cancer malignancy
Quick Look
Cell-specific multi-target mechanisms of cotinine in cervical cancer oncogenesis and progression
Quick Look
Biomarkers of the tumor microenvironment for prognostication of recurrence in glioma and targeting stemness using an adjuvant
Quick Look
Integrated multi-omics and SHAP analysis reveal the core mechanisms of metabolic reprogramming in lung adenocarcinoma
Quick Look
A NEK2/ZWINT–NDC80 regulatory axis drives bladder cancer progression and chemoresistance
Quick Look
Network toxicology and molecular docking identify BRCA1 as a functional target of the dietary carcinogen PhIP in colorectal cancer
Quick Look
Identification of FMR1 as a novel cancer prognostic and immunotherapy biomarker through renal cancer experimental validation and pan-cancer analysis
Quick Look
Identification of ZNF469 as a potential biomarker and therapeutic target for gastric cancer through integrated multi dataset analysis
Quick Look
Development and validation of a cuproptosis-immune prognostic signature for risk stratification and personalized therapy in cutaneous melanoma
Quick Look
Cancer-associated fibroblasts as a target in head and neck squamous cell carcinoma: bridging mechanisms to therapy with drugs, adjuvants, and nanotechnology
Quick Look
Identification of exosome-related genes signature based on bioinformatics and machine learning for prognostic prediction in colorectal cancer
Quick Look
Pan-cancer integrative profiling of immune-related lncRNAs unveils tumor microenvironment subtypes and prognostic biomarkers
Quick Look
A prognostic model for breast cancer based on mitochondria-associated endoplasmic reticulum membrane (MAM) signature genes